IFPI

President
Steve Alexander
steve@alexander.co.nz
Secretary
Leo Schep
leo.schep@toxinform.com

Dr Leo Schep

Mobile : +64 21 14897410  Email : leo.schep@toxinform.com

Dr Schep has been employed by the University of Otago from 1987 until 2019 (School of Pharmacy from 1987 to 1999 and the National Poisons Centre from 2000 to 2019). His expertise consists of providing poisons information concerning all aspects of human acute and chronic poisoning. Additionally, he lectures on Forensic Toxicology at the University of Otago. He has published over 50 peer-reviewed papers, 6 book chapters and a wide range of conference proceedings and other medical publications.
He has provided advice, and presented seminars, to the New Zealand Police, New Zealand Defence Force as well as Emergency Departments and other health care providers. He has also provided teaching seminars throughout the country, to various community organisations, Maraes and secondary schools.
He established his consultancy firm, ToxInform Ltd, in 2008 where he provides advise to a wide range of clients concerning human risks and exposures to various toxic chemicals, pharmaceuticals and recreational drugs. This has included toxicology reports and expert opinions in various court cases, both in Australia and New Zealand. He has worked with the High Court, Court of Appeal, and various district, employment and family courts.

Sample of his publications

Schep L, Poulsen H, Gee P. (2017) “Analytical Advances in Drug Detection of Piperazines” in “Detection of Misused Drugs”. Royal Society of Chemistry, London. ISBN: 9781782621577. Editor Wolff K. (http://pubs.rsc.org/en/content/ebook/978-1-78262-157-7).
Schep LJ, Slaughter RJ, Galea S, et al. (2016) Ibogaine for treating drug dependence. What is a safe dose? Drug and alcohol dependence. 166(1):1-5.
Gee P, Schep LJ, Jensen BP, Moore G, Barrington S. (2016) “Case series: toxicity from 25B-NBOMe – a cluster of N-bomb cases”. Clinical Toxicology. 54 (2): 141-146.
Schep LJ, Gee P, Tingle M, Galea S, Newcombe D. (2014) “Regulating novel psychoactive drugs: Innovation leading to compromise”. British Medical Journal. 349: g5085.
Schep LJ, Slaughter RJ, Beasley DMG. (2010) Clinical toxicity of methamphetamine. Clinical Toxicology 48(7):675–694.
Schep LJ, Watts, M. “Alpha-PVP: A novel amphetamine analogue with a deadly reputation”. NZ Doctor. March 30, 2016. Page 37.
Schep LJ. “Synthetic cannabinoids: the lows that follow the legal highs”. NZ Doctor. November 20, 2013. Page 21.

Sample of his media interviews etc

Methamphetamine contamination: Toxicologist Leo Schep explains the science

https://www.radionz.co.nz/national/programmes/nights/audio/2018652029/methamphetamine-contamination-toxicologist-leo-schep-explains-the-science

Leo Schep: Ecstasy not the safe party drug advocates claim

https://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=11469393
Nightly interview: Leo Schep

© Copyright 2018 | Independent Forensic Practitioners Institute | All Rights Reserved